Minisymposia
SUNDAY, APRIL 15
2:00 p.m. to 5:30 p.m.
Cellular and Molecular Biology
Apoptosis
Repression of Gene Expression
Experimental and Molecular Therapeutics
Mechanisms of Drug Resistance
Novel Agents
Immunology
Tumor-Induced Immune Suppression
Prevention Research
Preclinical Prevention Studies 1: Novel Agents
Tumor Biology
Antiangiogenesis and Vascular Normalization in Tumors
MONDAY, APRIL 16
9:30 a.m. to 1:00 p.m.
Carcinogenesis
Molecular Carcinogenesis 1
Cellular and Molecular Biology
Cistromes and Transcriptomes
Chemistry
Proteomics and Biomarker Discovery
Clinical Research
Biomarkers of Clinical Outcomes
Experimental and Molecular Therapeutics
HDAC Inhibitors 2: New Insights
Tumor Biology
Tumor Microenvironment 3
MONDAY, APRIL 16
1:00 p.m. to 4:30 p.m.
Cellular and Molecular Biology
Receptor-Mediated Signaling 3
What's New with p53 and the Family
Endocrinology
Steroid Hormone Signaling, Coregulators, and Crosstalk with Growth Factor Pathways
Epidemiology
Cancer Biology, Risk, and Prognosis among Minority Populations
Experimental and Molecular Therapeutics
Novel Molecular Mechanisms of Signaling Agents
Prevention Research
Preclinical Prevention Studies 2: Molecular Pharmacology in Animal Models
Tumor Biology
Tumor Microenvironment Interactions in Metastasis: From Hypoxia to Host
TUESDAY, APRIL 17
10:00 a.m. to 1:30 p.m.
Cellular and Molecular Biology
Cancer Epigenetics
Non-Receptor Mediated Signaling
Chemistry
Drug Discovery and Design 2: Targeted Design and Delivery
Clinical Research
Clinical Immunology and Biological Therapy
Epidemiology
Inflammation, Immunity, and Novel Pathways
Experimental and Molecular Therapeutics
Genetic and Antibody Based Experimental Therapies
Tumor Biology
Angiogenesis and Lymphangiogenesis in Tumor Metastasis
TUESDAY, APRIL 17
2:00 p.m. to 5:30 p.m.
Cellular and Molecular Biology
Cell Responses: Senescence and Autophagy
New Cancer-associated Loci
Experimental and Molecular Therapeutics
Pathways to Apoptosis
Experimental and Molecular Therapeutics
Target Identification and Validation: Large Scale Approaches
Immunology
Immunotherapy and Cancer Vaccines 4
Tumor Biology
Prostate Cancer Biology
WEDNESDAY, APRIL 18
8:30 a.m. to 12:00 p.m.
Carcinogenesis
Inflammation and Oxidative Stress in Carcinogenesis
Cellular and Molecular Biology
Integrated Genomic Analysis of Human Cancer
Pathways of Tumor Suppression and Oncogenesis
Clinical Research
Molecular Determinants of Patient Outcome
Experimental and Molecular Therapeutics
Chaperones and Novel Mechanisms of Cytotoxics
Targeted Therapeutic Development Utilizing Preclinical Models
Tumor Biology
Molecular Mechanisms of Breast Cancer Progression
Mouse Models of Cancer 6: Signaling Mechanisms in Initiation, Progression, and Therapeutics